Dashboard
Manage Tickers

VRNA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-suspends-overweight-rating-on-verona-pharma-plc-adr-maintains-100-price-target
Cantor Fitzgerald Suspends Overweight Rati...
10/08/2025 13:48:46

Cantor Fitzgerald suspends Overweight rating on Verona Pharma PLC ADR (NASDAQ:VRNA) and Maintains $100 price target

verona-pharma-announces-that-high-court-of-justice-of-england-and-wales-has-approved-its-acquisition-by-msd-for-107-per-american-depository-share-totaling-10b
Verona Pharma Announces That High Court Of...
10/06/2025 20:07:45

Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), a biopharmaceutical company focused on respiratory diseases, which e...

Core News & Articles
Verona Pharma Receives Shareholders Approv...
09/24/2025 20:11:28

LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (NASDAQ:VRNA) ("Verona Pharma"), ...

verona-pharma-to-present-phase-3-enhance-copd-analyses-at-ers-2025-highlighting-ohtuvayre-ensifentrine-benefits-on-lung-function-exacerbations-symptoms-and-quality-of-life
Verona Pharma To Present Phase 3 ENHANCE C...
09/16/2025 10:13:25

looking-into-verona-pharmas-recent-short-interest
Looking Into Verona Pharma's Recent Short ...
08/20/2025 20:00:37

verona-pharma-q2-eps-013-beats-004-estimate-sales-103138m-beat-92140m-estimate
Verona Pharma Q2 EPS $0.13 Beats $0.04 Est...
08/06/2025 21:48:41

Verona Pharma (NASDAQ:VRNA) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.04 b...

is-the-market-bullish-or-bearish-on-verona-pharma
Is the Market Bullish or Bearish on Verona...
07/18/2025 20:00:35

this-procter--gamble-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday
This Procter & Gamble Analyst Is No Longer...
07/14/2025 11:42:31

hc-wainwright--co-downgrades-verona-pharma-to-neutral-raises-price-target-to-107
HC Wainwright & Co. Downgrades Verona Phar...
07/14/2025 11:30:29

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Verona Pharma (NASDAQ:VRNA) from Buy to Neutral and raises the...

wells-fargo-downgrades-verona-pharma-to-equal-weight-lowers-price-target-to-107
Wells Fargo Downgrades Verona Pharma to Eq...
07/10/2025 12:32:20

Wells Fargo analyst Tiago Fauth downgrades Verona Pharma (NASDAQ:VRNA) from Overweight to Equal-Weight and lowers the price ...

btig-downgrades-verona-pharma-to-neutral
BTIG Downgrades Verona Pharma to Neutral
07/10/2025 11:39:00

BTIG analyst Thomas Shrader downgrades Verona Pharma (NASDAQ:VRNA) from Buy to Neutral.

jefferies-downgrades-verona-pharma-to-hold-lowers-price-target-to-107
Jefferies Downgrades Verona Pharma to Hold...
07/09/2025 19:58:00

Jefferies analyst Suji Jeong downgrades Verona Pharma (NASDAQ:VRNA) from Buy to Hold and lowers the price target from $140 t...

canaccord-genuity-downgrades-verona-pharma-to-hold-announces-107-price-target
Canaccord Genuity Downgrades Verona Pharma...
07/09/2025 19:55:03

Canaccord Genuity analyst Edward Nash downgrades Verona Pharma (NASDAQ:VRNA) from Buy to Hold and announces $107 price target.

nvidias-4-trillion-milestone-lifts-wall-street-whats-moving-markets-wednesday
Nvidia's $4 Trillion Milestone Lifts Wall ...
07/09/2025 18:19:30

Wall Street rose on Wednesday as investors shrugged off fresh trade uncertainty after the White House delayed the start of new ...

verona-pharma-rhythm-pharmaceuticals-aes-and-other-big-stocks-moving-higher-on-wednesday
Verona Pharma, Rhythm Pharmaceuticals, AES...
07/09/2025 15:06:14

merck-strikes-10-billion-deal-for-verona-secures-first-in-class-copd-drug
Merck Strikes $10-Billion Deal For Verona,...
07/09/2025 13:03:53

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/09/2025 12:07:32

Core News & Articles
Merck To Acquire Verona Pharma In $10B Dea...
07/09/2025 10:33:19

Acquisition aligns with Merck's science-led business development strategy and expands pipeline and portfolio of treatments ...

Core News & Articles
Financial Times Reported Earlier, Merck Ne...
07/09/2025 09:32:54

https://www.ft.com/content/bf1c2253-15b3-426a-975d-15ddca1d84a5https://www.ft.com/content/bf1c2253-15

why-aes-shares-are-trading-higher-by-over-10-here-are-20-stocks-moving-premarket
Why AES Shares Are Trading Higher By Over ...
07/09/2025 09:00:13

Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION